Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

Core Insights - Rapid Micro Biosystems, Inc. will release its fourth quarter and full year 2025 financial results on March 12, 2026, before the market opens [1] - A webcast conference call will be hosted by the management team at 8:30 a.m. ET on the same day, with a live audio webcast available on the company's website [2] Company Overview - Rapid Micro Biosystems is a life sciences technology company that provides automation solutions for the efficient manufacturing and safe release of healthcare products, including biologics, vaccines, cell and gene therapies, and sterile injectables [3] - The company's flagship product, the Growth Direct system, modernizes microbial quality control testing workflows in pharmaceutical manufacturing, enhancing speed, accuracy, operational efficiency, and compliance with data integrity regulations [3] - The company is headquartered in Lexington, Massachusetts, with manufacturing in Lowell, Massachusetts, and additional locations in Switzerland, Germany, and the Netherlands [3]